Skip to main content

Trial approval for PYC Therapeutics

15/08/2024 - 14:59

Bookmark

Save articles for future reference.

Perth biotech company PYC Therapeutics has hit another major milestone, gaining approval to move its first-in-class PYC-001 drug to human trials.

X

To read our articles you will need to either login or subscribe.